Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Aripiprazole IM Depot in Schizophrenia
NCT01129882Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Jun 2010
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 24
01
Overview
A Phase 3 trial of aripiprazole in schizophrenia, sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Jun 2010; status: completed.
02
Drugs
aripiprazole
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT01129882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01129882.